‘Grandma and grandpa aren’t going to figure this one out.’ Prescription-drug savings vanish in the Medicare shuffle

Biogen’s blockbuster multiple sclerosis drug Tecfidera is an example of how patients don’t always benefit from low-cost generic competition, researchers say
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.